Diabetes Project Leuven, Belgium.
Completed
- Conditions
- Diabetes mellitus type 2, adherence to guidelines, clinical inertia, primary care
- Registration Number
- NL-OMON21652
- Lead Sponsor
- ational Institute for Health and Disability Insurance, Belgium
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
All 379 primary care physicians (PCP’s) that actively execute their profession in the project region were invited to participate.
These PCP’s work in a semi-rural setting with 357.000 inhabitants in Belgium and predominantly serve Caucasian patients with diabetes mellitus type 2.
Exclusion Criteria
Type 1 diabetes mellitus patients. Patients not capable to provide informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoints of the study are the proportion of patients reaching the ADA-targets for three bio-clinical outcomes: <br /> <br>1. HbA1c < 7%<br /> <br>2. SBD </ 130 mm Hg<br /> <br>3. LDL-C < 100mg/dl.
- Secondary Outcome Measures
Name Time Method Secondary endpoints are individual improvements of 12 validated parameters, i.e. <br /><br><br>- HbA1c<br /> <br>- LDLC<br /> <br>- HDL-C<br /> <br>- Total Cholesterol<br /> <br>- SBP<br /> <br>- Diastolic Blood Pressure (DBP)<br /> <br>- Weight<br /> <br>- Physical exercise<br /> <br>- Healthy diet<br /> <br>- Smoking status<br /> <br>- Statin<br /> <br>- Anti-platelet therapy.